Answers are grounded in this paper and cite their sources.
De novo mutations are a cause of sporadic ALS and may also be underpinning smaller families with few affected ALS cases. It was not possible to ascertain if the origin of the de novo mutations was parental germline, zygotic or postzygotic during embryonal development. All ALS patients should be offered genetic counselling and genetic screening, the challenges of variant interpretation do not outweigh the potential benefits including earlier confirmed diagnosis and possible bespoken therapy.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: